Here are relevant reports on : sensor-fusion-market
-
Fusion Splicer Market by Offering (Hardware (Sheath Clamps, Electrodes, Electric ARC, CO2 Laser, Cleaver and Stripper), and Software & Services), Alignment Type (Core, and Cladding Alignment), Application, and Geography - Global Forecast to 2022
The fusion splicer market was valued at USD 570.5 Million in 2016 and is expected to reach USD 762.3 Million by 2022, at a CAGR of 4.72%. Moreover, the fusion splicer market registered a shipment of 65,735 units in 2016 and is expected to reach 97,353 units by 2022, at a CAGR of 6.52% during the forecast period. The base year considered for the study is 2016 and the forecast period is between 2017 and 2022.
- Published: April 2017
- Price: $ 4950
- TOC Available:
-
Nuclear Fusion Market by Technology (Inertial Confinement, Magnetic Confinement), Fuel (Tritium, Deuterium, Helium-3, Proton-Boron), End User (Industrial, Utilities, National Laboratories, and Research Institutes), and Region - Global Forecast to 2031
The global nuclear fusion market is projected to reach USD 33.77 billion by 2031. The key players include Commonwealth Fusion Systems (US), Tokamak Energy (UK), TAE Technologies (US), Helion (US), General Fusion (Canada), SHINE Technologies (US), Focused Energy Inc. (US), Type One Energy (US), Thea Energy (US), Zap Energy Inc. (US), Xcimer Energy (US), Realta Fusion (US), Lockheed Martin (US), Marvel Fusion (Germany), Alpha Ring (US), First Light Fusion (UK), Helical Fusion Co., Ltd. (Japan), OpenStar Technologies Limited (New Zealand), Proxima Fusion (Germany), Gauss Fusion (Germany), Novatron Fusion Group AB (Sweden), Renaissance Fusion (France), HB11 Energy Holding Pty Ltd (Australia), Pulsar Fusion (UK), and nT-Tao (Israel).
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Pedicle Screw System Market by Product Type (Monoaxial & Polyaxial Pedicle Screw), Surgery (Open Surgery, Minimal Invasive Surgery), Indication (Spinal Deformities, Spinal Trauma), Application (Thoracolumbar, Cervical Fusion) - Global Forecast to 2023
The global pedicle screw systems market is expected to reach USD 724.23 million by 2023 from USD 538.64 million in 2018, at a CAGR of 6.1%. The major factors driving the growth of this market are the increasing incidence of spinal cord injuries, the growing preference for minimally invasive surgeries, and a rising geriatric population. Key players in the pedicle screw systems market include DePuy Synthesis (US), Globus Medical (US), Zimmer Biomet (US), B. Braun (US), Medtronic (Ireland), and Stryker (US).
- Published: October 2018
- Price: $ 4950
- TOC Available:
-
Emotion Detection and Recognition (EDR) Market by Solution (Software Platforms, APIs & SDKs), Service (Managed Emotion AI, Integration & Deployment), Data Modality (Multimodal Data Fusion, Visual, Speech & Audio), Application - Global Forecast to 2031
The emotion detection and recognition market is projected to grow from USD 29.14 billion in 2026 to USD 43.29 billion by 2031 at a Compound Annual Growth Rate (CAGR) of 8.2% during the forecast period. The key players include Microsoft (US), AWS (US), Oracle (US), NiCE (Israel), Salesforce (US), Google (US), Qualtrics (US), Bosch (Germany), NEC (Japan), Genesys (US), IBM (US), Nemesysco (Israel), Smart Eye (Sweden), Uniphore (US), CallMiner (US), audEERING (Germany), Tobii (Sweden), Seeing Machines (Australia), Medallia (US), Sprinklr (US), Verint (US), Realeyes (UK), Observe.AI (US), Entropik (India), Behavioral Signals (US), Kairos (US), Noldus (Netherlands), Cognovi Labs (US), Cerence (US), MorphCast (Italy), Hume AI (US), and Vern AI (US).
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Respiratory Antivirals Market by Disease Type (URTI, Influenza, Bronchiolitis, Pneumonia, Measles, & Others), Drug Class (Nucleoside Analogues, Neuraminidase Inhibitors, Ion Channel Blockers, Fusion Protein Inhibitors) - Global Forecast to 2019
Over the years, there has been a significant increase in the number of viral respiratory infections in humans. As a result of this, the costs to the community have increased considerably owing to the growing number of physician visits and hospitalizations. Among approximately 200 viral respiratory pathogens, the most important viral pathogens include influenza and respiratory syncytial viruses (RSVs). Antiviral drugs play an important role in the prevention and treatment of these disorders.
- Published: December 2026
- Price: $ 4950
- TOC Available:
-
3D Printing Market Size, Share, Growth & Trends by Offering (Printers, Materials, Software, Services), Technology (Fused Deposition Modeling, Stereolithography), and Process (Powder Bed Fusion, Vat Photopolymerization) - Global Forecast to 2032
The 3D printing market is projected to grow from USD 16.43 billion in 2026 to USD 31.77 billion by 2032, growing at a CAGR of 11.6%. Key companies operating in the 3D printing market are Stratasys (US); EOS GmbH (Belgium); HP Development Company, L.P. (US); 3D Systems, Inc. (US); GE Aerospace (US); Materialise (Belgium); Nano Dimension (US); voxeljet AG (Germany); SLM Solutions (Germany); and Renishaw (UK); among others.
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Ophthalmology Drugs Market by Molecule (Faricimab, Aflibercept, Ranibizumab), Modality (Monoclonal Antibodies & Fusion Proteins), RoA (Intravitreal, Topical), Indication (AMD, Diabetic Retinopathy (DR), DME), End User - Global Forecast to 2030
The global ophthalmology drugs market, valued at US$18.34 billion in 2024, stood at US$19.52 billion in 2025 and is projected to advance at a resilient CAGR of 6.1% from 2025 to 2030, culminating in a forecasted valuation of US$26.28 billion by the end of the period.
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
Metal Implants and Medical Alloys Market by Type (Titanium, Stainless Steel, Cobalt Chrome), Application (Orthopedic, Dental, Spinal Fusion, Craniofacial, Pacemaker, Stent, Defibrillator, Hip, Knee, & Shoulder Reconstruction) - Global Forecast to 2024
The metal implants and medical alloys market is projected to reach USD 17.6 billion by 2024 from USD 11.2 billion in 2019, at a CAGR of 9.4%. Factors such as the growing number of trauma/accidental cases, the growing ageing population, and the rising prevalence of chronic disorders are driving the growth of the metal implants and medical alloys market. The prominent players in the metal implants and medical alloys market are Carpenter Technology Corporation (US), Royal DSM (Netherlands), Johnson Matthey Plc (UK), ATI Specialty Alloys & Components (US), Ametek Specialty Products (US), Aperam S.A. (Luxembourg), QuesTek Innovations LLC (US), and Fort Wayne Metals (US).
- Published: June 2019
- Price: $ 4950
- TOC Available:
-
Fusion Biopsy Market by Route Type (Transrectal, Transperineal), Product (Equipment, Consumables), Application (Prostate Cancer), End User (Hospitals), and Region - Global Forecast to 2029
The global fusion biopsy market, valued at US$0.61 billion in 2023, stood at US$0.65 billion in 2024 and is projected to advance at a resilient CAGR of 7.1% from 2024 to 2029, culminating in a forecasted valuation of US$0.91 billion by the end of the period. Some main drivers for the growth of the fusion biopsy market are the growing prevalence of prostate cancer, since it's among one of the most common serious health concerns for males on a global scale.
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
Orthobiologics Market by Product (Viscosupplementation, Synthetic Orthobiologics, DBM, BMP, PRP, BMAC, Allograft), Application (Fracture Recovery, Osteoarthritis, Spinal Fusion, Soft Tissue), End User (Hospitals, ASCs, Academia) - Global Forecast to 2022
The global orthobiologics market is projected to reach USD 6.06 Billion by 2022 from USD 4.66 Billion in 2017, at a CAGR of 5.4% during the forecast period. Factors such as rising burden of orthopedic injuries; increasing incidence of sports injuries and road accidents; increasing incidence of spinal fusion surgeries; risk factors associated with increasing aging population, obesity rate, & high incidence of musculoskeletal disorders; and growing patient preference for minimally invasive procedures are driving the orthobiologics market. The major players in the market are DePuy Synthes, Medtronic, Stryker, Zimmer Biomet, Harvest Technologies, Globus Medical, Orthofix International, RTI Surgical, K2M Group, Kuros Biosciences, Bioventus, NuVasive, SeaSpine, Arthrex, and Xtant Medical.
- Published: September 2017
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50